OTC · Financial Statements
MediPal Holdings Corporation (MAHLY) Financial Statements
$17.99
OTC: MAHLY
Market Cap $3.68B
Overview Financials Dividend MediPal Holdings Corporation most recently reported annual revenue of $4.05T, net profit of $45.1B, revenue has compounded at 4.7% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2022 2023 2024 2025 2026 Revenue $3.29T $3.36T $3.56T $3.67T $4.05T Operating Profit $45.6B $49.0B $47.3B $55.6B $56.4B Net Profit $29.4B $38.8B $41.5B $40.3B $45.1B EPS $131.41 $179.12 $195.83 $193.19 $218.90 Op Margin 1.4% 1.5% 1.3% 1.5% 1.4%
Balance Sheet (USD)
Metric 2022 2023 2024 2025 2026 Total Assets $1.71T $1.70T $1.80T $1.82T $1.93T Total Liabilities $1.06T $1.02T $1.06T $1.07T $1.13T Cash $260.4B $193.6B $230.2B $261.4B $290.3B Borrowings $30.1B $7.4B $1.5B $28.0M $0
Cash Flow (USD)
Metric 2022 2023 2024 2025 2026 Operating Cash Flow $61.2B $16.1B $61.8B $60.6B $49.4B Investing Cash Flow $-43.2B $-53.0B $-27.2B $-15.8B $2.8B Financing Cash Flow $-7.3B $-3.9B $-14.1B $-13.4B $-16.5B Net Cash Flow $20.4B $-66.9B $34.5B $31.3B $13.2B Free Cash Flow $42.3B $2.6B $42.4B $48.1B $42.3B
Valuation & Return Ratios
Metric Value PEG Ratio 1.94 EV / EBITDA 2.61 FCF Yield 0.00% Quick Ratio 1.11 Interest Coverage 4091.08 Return 1Y 4.57% Return 3Y 9.14% Return 5Y -4.39%
Screens featuring this stock